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Abstract Syncoilin is a 64-kDa intermediate filament
protein expressed in skeletal muscle and enriched at
the perinucleus, sarcolemma, and myotendinous and
neuromuscular junctions. Due to its pattern of cellular
localization and binding partners, syncoilin is an ideal
candidate to be both an important structural component of
myocytes and a potential mediator of inherited myopathies.
Here we present a report of a knockout mouse model for
syncoilin and the results of an investigation into the effect
of a syncoilin null state on striated muscle function in 6–8-
week-old mice. An analysis of proteins known to associate
with syncoilin showed that ablation of syncoilin had no
effect on absolute expression or spatial localization of
desmin or alpha dystrobrevin. Our syncoilin-null animal
exhibited no differences in cardiotoxin-induced muscle
regeneration, voluntary wheel running, or enforced tread-
mill exercise capacity, relative to wild-type controls.
Finally, a mechanical investigation of isolated soleus and
extensor digitorum longus indicated a potential differential
reduction in muscle strength and resilience. We are the first
to present data identifying an increased susceptibility to
muscle damage in response to an extended forced exercise
regime in syncoilin-deficient muscle. This study establishes
a second viable syncoilin knockout model and highlights
the importance of further investigations to determine the
role of syncoilin in skeletal muscle.
Introduction
Syncoilin is a recently described member of the interme-
diate filament (IF) family of proteins (Newey et al. 2001).
So named for its enrichment at the neuromuscular synapse
and its coiled-coil-forming rod domains, the syncoilin gene
has been mapped to chromosome 1 in humans and to
chromosome 4 in mice. The syncoilin gene comprises five
coding exons that generate a 64-kDa protein product (Ne-
wey et al. 2001). Following its discovery, subsequent yeast
two-hybrid screening analysis showed that the IF protein
desmin and the dystrophin-related protein a-dystrobrevin
were syncoilin binding partners in striated muscle (Newey
et al. 2001; Poon et al. 2002). Histologic studies utilizing
immunofluorescent and confocal microscopy have con-
firmed that syncoilin colocalizes under normal conditions
with both desmin and a-dystrobrevin (McCullagh et al.
2007; Newey et al. 2001; Poon et al. 2002).
One distinctive feature of syncoilin is its apparent
departure from spontaneous dimer-forming behavior. Syn-
coilin does not appear to form a filamentous network by itself
or with other IF proteins, although it may form filaments in
certain myopathies (Brown et al. 2005; Poon et al. 2002).
Syncoilin is highly expressed in skeletal and cardiac
muscle, and in the former it is concentrated at the sarco-
lemma, Z-lines, perinuclear space, myotendinous junction,
and neuromuscular junction (McCullagh et al. 2007;
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Newey et al. 2001; Poon et al. 2002). Within the skeletal
muscle fiber population, syncoilin is enriched at the sar-
colemma and sarcoplasm of oxidative muscle fibers
(McCullagh et al. 2007). Thus, the localization of syncoilin
parallels that of desmin, to which it binds directly.
Desmin is the dominant IF protein in mature muscle and
has been predicted to play a major role in protecting
muscle from mechanical stress and is important for muscle
integrity (Capetanaki et al. 2007; Costa et al. 2004). An
analysis of the tensile properties of single desmin filaments
has shown that it exhibits a nonlinear response to strain
(notably above 50% extension) and a tensile strength of at
least 240 mPa (Kreplak et al. 2008). These properties add
further weight to the theory that desmin acts as both a
mediator of myocyte spatial organization and provides a
physical link between adjacent contractile units.
Desmin knockout (des-/-) mice show a skeletal
myopathy as well as a cardiomyopathy, and desmin aber-
rations have been linked to disease in humans (Li et al.
1996; Milner et al. 1996; Olive et al. 2004). A study of
exercise ability showed a reduction in the capacity of
des-/- mice to perform both voluntary wheel running and
enforced treadmill exercise. Most interestingly, the study
showed that an absence of desmin was not sufficient to
increase serum creatine kinase levels (a marker of sarco-
lemmal damage) (Haubold et al. 2003).
We have previously shown that the levels of syncoilin
are reduced by 60% in these animals and that the subcel-
lular location of syncoilin is altered. In the des-/- mice,
syncoilin is lost from the Z-lines and reduced at the sar-
colemma (McCullagh et al. 2007). Alterations in syncoilin
expression have been reported for other myopathies,
including elevated levels in dystrophic muscles of mdx
mice and in atrophic muscle fibers of patients with neu-
rogenic disorders (Brown et al. 2005; Newey et al. 2001).
Although there is clear evidence showing that syncoilin
binds directly to both a-dystrobrevin and desmin, whether
syncoilin has the ability to bind to these proteins simulta-
neously and thus form a link between the cytoskeletal IF
network and the sarcolemma via the dystrophin associated
protein complex (DAPC) remains to be investigated.
This potential linking of the DAPC to the IF network via
syncoilin is of interest since the lateral transmission of
contractile force to the extracellular matrix is believed to be
mediated mainly through IF proteins (Lieber et al. 2002).
The DAPC is a trans-sarcolemmal protein complex
expressed in both muscle and nonmuscle tissues (Blake
et al. 2002). Due to its expression patterns and its large and
varied number of protein constituents, the DAPC is con-
sidered to play both a structural and a signaling role. A
detailed review of the DAPC with respect to its structure
and predicted role in normal skeletal muscle function and
myopathy is outside of the scope of this article. The reader
is referred to comprehensive reviews by Blake et al. (2002)
and Davies and Nowak (2006) for further detail.
Briefly, the DAPC consists of the a- and b-dystrogly-
cans and the sarcoglycans at the sarcolemma, along with
the cytoplasmic components syntrophin and dystrobrevin.
It is now well established that mutations in dystrophin and
the sarcoglycans result in a muscular dystrophy. Aberra-
tions in both desmin and a-dystrobrevin have been
implicated in muscular dystrophies, although in the case of
a-dystrobrevin its role in the pathophysiology of neuro-
muscular disease is far from clear (Jin et al. 2007; Jones
et al. 2003; Paulin et al. 2004; Rees et al. 2007). The
DAPC stabilizes the sarcolemma by linking the extracel-
lular matrix (via an extracellular interaction of laminin-2
with DAPC component a-dystroglycan) with the internal
cytoskeleton and contractile apparatus of myocytes (via an
interaction of dystrophin with F-actin and indirectly with
the IF network via a-dystrobrevin) (Blake et al. 2002).
In view of the findings that the loss of either desmin or
dystrobrevin results in the development of muscular dys-
trophy in association with changes in the distribution of
syncoilin, we decided to test the hypothesis that loss of
syncoilin might have an adverse effect on myocyte function.
We generated a syncoilin knockout mouse by standard
techniques of homologous recombination in embryonic
stem (ES) cells and a Cre-loxP-mediated conditional gene-
targeting approach. Such null mutants would allow the
investigation of the role of syncoilin in skeletal and cardiac
muscle. This strategy allowed us to produce two lines of
mice: conditional (sync-floxed) and constitutive syncoilin
(sync-/-) knockout mice. Constitutive deletion of syncoi-
lin resulted in a viable mouse, precluding the need for tissue-
specific excision of the syncoilin gene. In this article we
present the results of a molecular and phenotypic charac-
terization of striated muscle from a novel sync-/- mouse.
Materials and methods
Animals and antibodies
All mice were bred in-house and genotyped by standard PCR
methods. All animal experiments were performed according
to guidelines and protocols approved by the Home Office.
Antibodies used were anti-syncoilin-FP 81, anti-desmin
(Abcam8592), anti-desmin monoclonal antibody (DE-U-10;
Sigma), anti-dystrobrevin-1 and -2 antibody b1CTFP (Blake
et al. 1998), anti-dysbindin antibody (Benson et al. 2001;
Newey et al. 2001), anti-a-actinin mouse (N40; Santa Cruz),
anti-a-actinin antibody (EA-53; Sigma) and anti-dystrophin
antibody (Dys-2; Novacastro). A synemin antibody (anti-
Syn-3) that detects both a- and b-synemin was generated as
previously described (Mizuno et al. 2004).
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Gene targeting and generation of syncoilin knockout
mice
The targeting construct is shown in Fig. 1. Genomic
regions of the syncoilin gene were amplified by PCR from
a 129/Sv bacterial artificial plasmid (Wellcome Trust
Sanger Institute, Cambridge, UK) which contained the
syncoilin locus. The targeting construct was assembled in
the pBluescript II KS+ vector. The 50 arm of homology
consisted of a 1.6-kb fragment upstream of syncoilin exon
2 followed by a loxP site and neomycin flanked by frt
recombinase sites. The 30 arm of homology was a 5.9-kb
fragment containing exon 2 followed by a loxP site. The
targeting vector was verified by sequencing and linearized
with NotI before electroporation into E129/sv ES cells.
Four hundred G418-resistant ES clones were selected for
screening for homologous recombination by PCR and
Southern blotting. Genomic DNA isolated from each clone
was digested with NcoI and analyzed by Southern blotting.
A 50 internal probe and 30 external probe (indicated in
Fig. 1) were generated from mouse E129 genomic DNA.
Southern blots were hybridized with radiolabeled probes
and visualized by autoradiography. The 50 internal probe
was used to confirm recombination of the 50 arm of the
targeting vector, where the wild-type allele is indicated by
a band at 2.3 kb, and a 3.5-kb band represents the correctly
targeted allele. Hybridization of blots with the 30 external
probe was used to verify recombination of the 30 arm of the
targeting vector, where the wild-type allele is represented
by a band at 8.2 kb, and a 6.3-kb band represents the
correctly targeted allele.
Generation and genotyping of mice
Two independent correctly targeted ES clones were micro-
injected into blastocysts from C57BL/6 mice. Chimeric
mice were bred with transgenic mice ubiquitously express-
ing Cre recombinase under the cytomegalovirus promoter
(CMV), to generate germline-transmitted syncoilin hetero-
zygous (sync+/-) mice. Sync+/- mice were intercrossed to
generate homozygous syncoilin null (sync-/-) mice. Off-
spring from intercrosses were genotyped by PCR analysis of
mouse tail DNA using the following primers: forward
(wtFw), 50-ATGAAGTGATGTAAGCAGAGACTAGC-30;
reverse(wtRv), 50-GATAGAGAATGTCCTCTAGGTTCA
CAG-30; deletion indicator primer (DEx2Rv), 50-TCCT
AATCCTAACCCTACCCTAACTAA-30.
RNA extraction and RT-PCR
Total RNA was prepared from skeletal and cardiac muscle
of sync+/+ and sync-/- mice. Dissected tissue was snap-
frozen and milled in liquid nitrogen immediately before
total RNA extraction using Trizol (Invitrogen) according to
the manufacturer’s instructions. Total RNA (300 ng) was
reverse-transcribed into cDNA using random decameric
primers and superscript II reverse transcriptase (Invitro-
gen). Generated cDNA was used as a template to perform
standard PCR analysis.
Specific primers annealing to exon 2 and exon 5 (for-
ward, 50-AACTTCAGAACAGGAACCTGGAGGAC-30;
reverse, 50-CACTGAAATCAGTACCAGCAGCCTAC-30)
were used to amplify and test for the presence of syncoilin
transcript in sync+/+ and sync-/- muscles. Standard
exonic GAPDH primers were run on duplicate samples as a
control for the cDNA template.
Protein preparation and immunoblotting
Skeletal or cardiac muscles were snap-frozen immediately
after dissection in liquid nitrogen and stored at -80C until
use. The tissue was homogenized in 300 ll cold Newcastle
buffer (75 mM Tris pH 6.8, 3.8% SDS, 4 M urea, and 20%
glycerol) with protease inhibitor cocktail (Sigma). Protein
quantification was performed using the Bio-Rad Dc Protein
Assay according to the manufacturer’s protocol. Total pro-
tein (40 lg) was separated on 8 or 10% SDS polyacrylamide
gels (Bio-Rad) and electrophoretically transferred to nitro-
cellulose membranes. After blocking membranes overnight
at 4C in Tris-buffered saline containing 0.1% (v/v)
Tween20 (TBS-T) and 5% nonfat dry milk, blots were
incubated for 1 h with primary antibody and washed three
times in TBS-T prior to incubation with horseradish per-
oxidase conjugated IgG in blocking buffer. Membranes
were washed as previously described and developed using
ECL detection reagents (Amersham) as per the manufac-
turer’s instructions. Blots were stripped at 50C for
reprobing with different antibodies. Exposed film was
scanned with a HP Scanjet 5400c.
Single myofiber preparations
Mouse flexor digitorum brevis muscles (FDBs) were enzy-
matically dissociated using an established protocol (Brown
and Schneider 2002; Woods et al. 2004). The FDB was
dissected free and placed into 1 mg/ml of collagenase (Type
1, Sigma) in Ringer buffer (119 mM NaCl, 5 mM KCl,
1.25 mM CaCl2, 1 mM MgSO4, 1 mM KH2PO4, 10 mM
glucose) at 37C for 1.5 h. Collagenase activity was stopped
by washing the muscle with warmed Ringer’s solution and
the muscle was gently triturated using a Pasteur pipette until
single fibers were isolated. One hundred fifty microliters of
Ringer’s solution containing FDB single fibers was spread
across laminin-coated glass bottom culture dishes (Matek
Corp., Part No P35G-1.0) and incubated in 5% CO2 at 37C.
After 2 h, Ringer’s solution was removed and the dish was
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flooded with 4% PFA/PBS for 5 min to fix the fibers.
This method yielded approximately 100-200 fibers per dish.
The fibers were then permeabilized in 0.1% Triton/PBS and
then processed for immunolabeling.
Primary antibodies were diluted in PBS containing 10%
FCS and applied to the fiber preparations. After an over-
night incubation at 4C, fiber preparations were rinsed in
PBS followed by incubation with secondary antibodies
(Molecular Probes); Alexa fluor 594 and/or Alexa fluor 488
conjugated IgG diluted (1:2000) in PBS, 10% FCS for 2 h
at room temperature. Finally, fiber preparations were
washed thoroughly in PBS and mounted in an aqueous
medium (VectorShield) with DAPI. Finished preparations
were viewed under a Zeiss fluorescent photomicroscope or
Zeiss 410 confocal laser-scanning microscope. Digital
images were extracted using Axiovision LE 4.3 software.
Measurement of contractile properties
Mechanical measurements of skeletal muscle performance
in vitro were performed using a previously described pro-
tocol (with minor adaptations) (Moens et al. 1993). Briefly,
extensor digitorum longus (EDL) and soleus muscles were
dissected from 8-week-old male mice killed by cervical
dislocation. The muscles were pinned out in oxygenated
Ringer’s solution at room temperature to a length approx-
imating that seen in situ. Oxygenated (95% O2/5% CO2)
mouse Ringer’s solution (pH 7.4) was made up to include
118 mM NaCl, 24.8 mM NaHCO3, 4.75 mM KCl,
2.54 mM CaCl2, 11.8 mM MgSO4, 11.8 mM KH2PO4, and
10 mM glucose. Muscles were experimented on within 4 h
of excision. The freshly dissected muscles were mounted
onto the muscle lever of the Intact Muscle Measurement
System (Aurora Scientific Inc.) using 5-0 silk suture, and
maintained throughout the protocol at room temperature in
oxygenated Ringer’s solution. The muscles were stimu-
lated using platinum electrodes connected to a Aurora
701B stimulator. The optimum length was identified, and
then the maximum isometric tetanic force was measured
(EDL, 120 Hz, 500 ms; soleus, 80 Hz, 800 ms). Force
measurements were normalized to muscle cross-sectional
area. The wet weight of the muscles was recorded at the
end of the experiment. Data were captured and analyzed
using the DMC/DMA Dynamic Muscle Control and
Analysis software (Aurora Scientific Inc.).
Cardiotoxin-induced damage of hind limb muscle
Sex-matched adult mice were induced and maintained under
isofluorane inhalation anesthetic as discussed above. A small
incision was made to expose the tibialis anterior. Using a
100-ll insulin syringe, 50 ll of a 10 lM solution of Car-
diotoxin 1 (Sigma Aldrich, Dorset, UK) dissolved in sterile
PBS was introduced into the muscle belly. The overlying
skin was sutured to close the wound. The contralateral limb
was treated with an identical volume of PBS to serve as a
control. Three mice of each genotype were treated for each
timepoint. Following treatment, mice were aged for 1, 3, 5, 7,
or 21 days. Treated and control tibialis anterior muscle for
histologic analysis was dissected, embedded in OCT, and
snap-frozen in liquid nitrogen-cooled isopentane. Treated
and control tibialis anterior muscle for RNA analysis was
dissected and snap-frozen in liquid nitrogen.
Morphologic analysis of myoregeneration following
cardiotoxin treatment
OCT-embedded cardiotoxin-treated muscle and PBS-trea-
ted tibialis anterior muscle were sectioned on a cryostat to
a thickness of 9–12 lm. Sections were air-dried at room
temperature, rapidly fixed in absolute ethanol, then stained
with hemotoxylin and eosin and mounted in an aqueous
mounting media using standard histologic techniques.
Analysis of myoregeneration marker induction
Total RNA extraction and generation of cDNA from
excised cardiotoxin- and PBS-treated tibialis anterior
Fig. 1 Targeting of the syncoilin gene. (a) The top of the diagram
shows the targeting DNA vector with relevant restriction sites,
constructed by subcloning genomic syncoilin fragments, a pgk-Neo-
positive selection cassette, and a CMV-DTA-negative selection
cassette into a modified pBluescript vector. The genomic syncoilin
fragments (short 50 arm and long 30 arm) were PCR amplified from a
bacterial artificial chromosome. The long ‘‘arm’’ was modified by
insertion of a loxP site and NcoI restriction site after exon 2. Filled
boxes depict exons, loxP sites are shown as filled arrows, and frt in
open boxes signify flp recombinase sites. The second diagram is the
relevant genomic locus of syncoilin. Probes used for Southern blotting
analysis of homologous recombination events are shown as black bars
below intronic and exon regions; ext, external probe; int, internal
probe; and ex2, exon 2 probe. Primers used to genotype mice are
shown as horizontal arrows. The third diagram represents the
conditional (floxed) allele after homologous recombination in ES
cells. The bottom diagram shows the allele after in vivo Cre-loxP-
mediated deletion of exon 2. PGK-Neo, neomyocin gene under the
phosphoglycerine kinase promoter; CMV-DTA, diphtheria toxin A
gene under the cytomegalovirus promoter. (b) Southern blot of NcoI-
digested genomic DNA from two correctly targeted ES clones (+/-)
and a wild-type (+/+) clone. The upper panel shows the autoradiog-
raphy after hybridization with a 30 external probe, shown in (a). The
8.2-kb and 6.28-kb bands represent the expected wild-type and
targeted alleles, respectively. The lower panel shows the same clones
reprobed with a 50 internal probe and expected bands 2.3 kb and 3.5 kb
were detected for wild-type and targeted alleles, respectively. (c)
Representative PCR genotype for wild-type (+/+), heterozygous
(+/-), and homozygous (-/-) mice using a triple primer set shown in
panel A. (d) RT-PCR analysis of RNA extracted from tibialis anterior
muscle (TA), soleus (Sol), and heart (Hrt) using primers from exons
2 and 5 of the syncoilin gene (see Methods). A 500-bp fragment was
amplified from sync+/+ but not from sync-/- mouse RNA. GAPDH
primers were included as a control for the cDNA template
c
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tissue were performed as described above. Semiquanti-
tative PCR analysis of the cell cycle-dependent kinase
inhibitors p21CIP1, p27KIP1, p57KIP2 and myogenin
was performed as described previously (Koo et al.
2007).
Measurement of voluntary wheel running activity
To investigate the effect of syncoilin ablation on activity
levels, we monitored voluntary wheel running in two
groups (n = 6) of 6-week-old male sync+/+ and sync-/-
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mice. Mice were placed in individual cages supplemented
with a monitored running wheel. Following an acclimati-
zation period of 1 week, the total number of wheel
revolutions performed by each animal was electronically
recorded for an additional 7-day period using the ClockLab
software suite (Actimetrics Software).
Measurement of enforced treadmill exercise capacity
and resultant muscle damage
Treadmill exercise is a well-established means of analyzing
muscle function in rodents (Armand et al. 2003). Two
groups of 6-week-old male sync+/+ and sync-/- mice
were exercised on a motorized treadmill (Exer6-M,
Columbus Instruments). The regimen consisted of 5 days
of familiarization running (10 m/min for 15 min), 9 days
of endurance running (17 m/min for 45 min), and 1 day of
exhaustion running (17 m/min for 45 min followed by an
increase in speed of 1 m/min for 15 min). Each of the
endurance/exhaustion running stages began with a 5-min
warm-up period at a speed of 10 m/min. Animals were
rested for 2 days after each 5-day block of running. The
weight of each animal was recorded before and after each
running session.
Animals were killed immediately following the final
running session and approximately 100 ll of venous blood
was collected from the exposed jugular vein. Following a
3-h incubation on wet ice, serum was isolated by centri-
fugation in a benchtop centrifuge for 5 min at 14,000 rpm.
Serum creatine kinase (CK) analysis was performed using a
kinetic UV serum analysis according to manufacturer’s
instructions (OSR6179, Olympus R&D, Ireland). Muscle
was dissected for hemotoxylin and eosin staining as
described previously. Evans Blue staining of isolated
muscle was performed in 1 ml of mouse Ringer’s solution
supplemented with 0.1% (w/v) Evans Blue dye. Muscle
was incubated in solution for 2.5 h at 37C before being
washed in mouse Ringer’s solution and embedded in OCT
as described previously.
Results
Generation of gene-targeted syncoilin-null mice
We generated homozygous syncoilin knockout (sync-/-)
mice by deleting the gene by in vivo Cre-loxP-mediated
excision of exon 2, which encodes 85% of the amino acid
sequence (Fig. 1a). This strategy was predicted to ensure the
ablation of functional syncoilin expression in knockout
animals. The targeting vector was electroporated into E129/
sv embryonic stem (ES) cells, and 167 clones were screened.
Twenty-four clones were identified that had undergone
homologous recombination (example shown in Fig. 1a).
Two independent clones were each injected into blastocysts
from C57BL/6 mice and then reimplanted to generate chi-
meric mice, bearing the floxed targeted syncoilin allele.
Chimeric mice were bred with female CMV-Cre-expressing
transgenic mice to excise exon 2 of syncoilin in vivo and give
rise to germline-transmitted heterozygous (sync-/+) mice.
In vivo mediated excision of exon 2 was verified by PCR
genotyping. Heterozygous mice were interbred to generate
homozygous syncoilin knockout (sync-/-) mice, which
were confirmed by PCR genotyping (Fig. 1c) and RT-PCR
analysis for exons 2–5 of RNA from tibialis anterior, soleus,
and heart muscles (Fig. 1d). Different genotypes (sync+/+,
sync +/-, and sync -/-) were obtained in the expected
Mendelian ratio. Syncoilin-null mice were viable and
were indistinguishable from their wild-type littermates in
appearance, behavior, and body weight.
Syncoilin protein analysis in sync-/- mice
Western blotting analysis of muscle protein from sync-/-
mice with a polyclonal-antibody recognizing full-length
(FL) syncoilin protein confirmed that we had ablated syn-
coilin expression (Fig. 2). Immunoblotting of the above
muscle samples with an antibody recognizing an amino
terminal (N) epitope (amino acids 1–146; encoded by
exons 1 and 2), which includes the translation initiation
site, gave the same results as the full-length syncoilin
antibody, indicating that no aberrant syncoilin protein
could be detected in sync-/- tissues.
Fig. 2 Western blot analysis of syncoilin and associated muscle
proteins. Images show altered syncoilin expression in +/+, +/-, and
-/- animals, without a resultant change in syncoilin-associated
proteins
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Analysis of syncoilin-binding proteins and other muscle
proteins in sync-/- mice
DAPC-associated and syncoilin-binding partner proteins
were quantified by Western blotting from total skeletal and
cardiac muscle protein prepared from sync+/+, sync+/-,
and sync-/- mice. Binding partners of syncoilin, desmin
and a-dystrobrevin were unaffected in sync+/+ and
sync-/- mouse skeletal or cardiac muscle (Fig. 2). An
antibody recognizing synemin isoforms H and M revealed
no variation in muscles from the different syncoilin mouse
genotypes (Fig. 2). Equal protein loading was demon-
strated by similar a-actinin levels between samples.
To assess if the absence of syncoilin affects the sub-
cellular localization of syncoilin-binding proteins, the
sarcomeric Z-lines, or other cytoskeletal proteins, we
performed immunofluorescence on isolated myofibers.
Fibers immunostained for desmin revealed no change in
their normal location, with fibers from both sync+/+ and
sync-/- mice showing normal localization to Z-lines
and myotendinous junctions (ends of myofibers) (Fig. 3).
a-Dystrobrevin immunostaining (data not shown) also
exhibited a normal distribution in both sync+/+ and
sync-/- fiber preparations. Thus, the subcellular locali-
zation of known syncoilin-binding partners is not
dependent on the presence of syncoilin in muscle. Immu-
nostaining of fibers for the Z-line protein a-actinin gave the
expected Z-disc striated pattern staining in both sync+/+
and sync-/- myofibers (Fig. 3).
Morphology of skeletal and cardiac muscle in sync-/-
mice
We examined the morphology of the more highly active
muscles in 8-week-old mice by light microscopy of
hematoxylin and eosin-stained sections of soleus, dia-
phragm, and heart from sync+/+ and sync-/- mice
(Fig. 4). Histologic analysis revealed no gross differences
between genotypes, and there was no sign of any dystro-
phic features or abnormal morphology in skeletal and
cardiac muscle from sync-/- mice.
Absence of syncoilin reduces contractile function in
skeletal muscles
To investigate the effect of syncoilin ablation on maximum
isometric force generation, we measured force production
in isolated soleus and extensor digitorum (EDL) muscles
from 8-week-old sync+/+ and sync-/- mice. Four EDL
muscles were assayed for each genotype. For the soleus
analysis, eight sync+/+ and six sync-/- muscles were
assayed. Isometric contractile testing of EDL muscles from
sync-/- mice revealed a strongly significant decrease in
normalized maximum force generation of -27.9% com-
pared with sync+/+ mice (25.86 N/cm2 vs. 35.89 N/cm2;
p \ 0.05) (Fig. 6a), whereas there was no significant dif-
ference observed between the soleus muscles of sync+/+
and sync-/- mice (Fig. 5).
Ablation of syncoilin does not elicit a morphologic
change in the rate of myoregeneration
To investigate any changes in muscle regeneration due to
the absence of syncoilin expression, we assessed regener-
ation at five time points, 1, 3, 5, 7, and 21 days, following
the intramuscular administration of cardiotoxin to the tib-
ialis anterior muscle in sync+/+ and sync-/- mice.
Figure 6a shows representative images of muscle regen-
eration from the sync+/+ and sync-/- groups (n = 3 for
each genotype) across the five time points. No obvious
differences in degeneration, infiltration, or regeneration
(including the number of centralized nuclei at 21 days)
were observed between sync+/+ and sync-/- animals.
Ablation of syncoilin does not elicit an alteration in
markers of myogenic differentiation
To investigate any potential difference in the kinetics
of skeletal myocyte regeneration between sync+/+ and
sync-/- animals, we performed a semiquantitative
assessment of the relative RNA levels of the cell cycle-
dependent kinase inhibitors p21CIP1, p27KIP1, p57KIP2
and myogenin in cardiotoxin-treated tibialis anterior muscle
Fig. 3 Immunostaining of single-fiber preparations from flexor
digitalis brevis in sync+/+ and sync-/- mice. Localization of
syncoilin to the Z-lines, sarcolemma, and MTJ is evident in the
sync+/+ animal and lost in the sync-/- animal. Desmin and
a-actinin organization shows no evidence of disruption as a result
of syncoilin ablation. (a) Syncoilin staining across whole fiber.
(b) Desmin staining across whole fiber. (c) Syncoilin staining at Z-
lines. (d) Desmin staining at Z-lines. (e) a-Actinin staining at Z-lines
K. J. A. McCullagh et al.: Muscle function in the C57BL6/SV129 syncoilin knockout mouse 345
123
at 1, 3, 5, and 7 days after administration. An increase in cell
cycle-dependent kinase inhibitors can be correlated with the
initiation of myogenic differentiation at the expense of cell
cycling. As such, these transcript levels can be used as
markers of myoregeneration kinetics (Koo et al. 2007). No
obvious difference in transcript levels was detected between
the sync+/+ and sync-/- animals, indicating that the
regeneration kinetics of skeletal muscle regeneration are not
altered by the ablation of syncoilin (Fig. 6b).
Ablation of syncoilin does not produce a statistically
significant difference in voluntary wheel running
A strong interanimal variation in running levels was
identified in both groups (sync+/+ and sync-/-) of age-
and sex-matched mice. Total individual (A) and group
average (B) revolution counts are shown in Fig. 7 Indi-
vidual cage positions are presented in paired form to
compensate for any potential differential effect in
Fig. 4 Hematoxylin and eosin
staining of highly solicited
muscles, soleus, diaphragm, and
heart, from 8-week-old sync+/
+ and sync-/- mice. No
morphologic differences were
noticed in any muscle types
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environment. Two-tailed analysis using Student’s t test did
not identify a statistically significant difference between
the averaged activity scores (p = 0.57) of the sync+/+ and
sync-/- groups.
Ablation of syncoilin induces increased muscle damage
without producing an observable difference in enforced
treadmill running ability
An analysis of the enforced exercise capacity of sync+/+
and sync-/- mice failed to demonstrate a reduction in the
ability of the sync-/- group to complete the prescribed
exercise protocols. Eighty-three percent of sync+/+ and
100% of sync-/- mice successfully completed the final
60-min exhaustion test, reaching a maximum speed of
32 m/min after 60 min of running. All animals continued
to gain weight normally over the course of the study (data
not shown). Figure 8 shows the results of a histologic
examination of muscle morphology following 15 running
sessions. No obvious differences in the gross morphology
of sync+/+ and sync-/- transverse sections were detec-
ted. A very small number of centralized nuclei were
detected in both sync+/+ and sync-/- tibialis anterior
sections. Evans Blue staining of isolated muscle did not
indicate increased dye penetration (and therefore sarco-
lemmal damage) in sync-/- muscle.
CK analysis of serum taken from sync+/+ and sync-/-
animals (n = 6 per genotype) immediately following the
completion of their running protocol showed a significant
(p \ 0.05, two-tailed Student’s t test) increase in serum CK
levels in the sync-/- population (Table 1).
Discussion
Syncoilin is a 64-kDa intermediate filament-like protein
expressed in skeletal and cardiac muscle that is found to be
enriched at the perinucleus, the Z-lines, and at the sarco-
lemma and neuromuscular junction (Newey et al. 2001).
Previous studies have shown that syncoilin interacts with
both a-dystrobrevin (a DAPC component) and desmin (the
major intermediate filament expressed in mature myocytes)
(Newey et al. 2001; Poon et al. 2002). By ablating in
excess of 80% of the syncoilin-coding sequence, we have
generated a mouse model that is null (-/-) for syncoilin
expression.
Developmentally, sync+/+ and sync-/- mice are
indistinguishable. Protein expression analysis of the syn-
coilin-binding partners desmin and a-dystrobrevin failed to
demonstrate a difference in their net concentrations in
muscle derived from sync+/+ and sync-/- mice. Immu-
nofluorescent staining of single-fiber preparations of flexor
digitalis brevis muscle demonstrated no difference in des-
min or a-dystrobrevin localization between sync+/+ and
sync-/- mice. Together, these data indicate that syncoilin
is not essential for either the correct cellular localization or
expression of these proteins (Figs. 2 and 3).
The treatment of skeletal muscle with myonecrotic
cardiotoxin induces widespread necrosis followed by a well
characterized cascade of satellite cell activation, prolifer-
ation, differentiation, and maturation (Shi and Garry 2006).
Our histologic analysis of cardiotoxin-treated tibialis
anterior muscle yielded no detectable difference in regen-
erating muscle at any of the time points between sync+/+
and sync-/- mice. Semiquantitative PCR analysis of
myogenin, p21, p27, and p57 expression in cardiotoxin-
treated tissue also failed to elicit a noticeable difference in
transcript levels. When their expression is upregulated,
these proteins act to initiate myogenic differentiation and
prevent the cell from re-entering the cell replication cycle
(Koo et al. 2007). These findings indicate that a lack of
syncoilin does not obviously retard muscle tissue regen-
eration and that thus syncoilin is unlikely to play an
essential role in this process. The results of both our vol-
untary running and enforced treadmill exercise studies
indicate that phenotypically syncoilin is dispensable for the
normal mechanical function of striated mucle under exer-
cise conditions.
Fig. 5 Contractile parameters
of muscles from 8-week-old
mice. Maximum isometric force
of EDL and soleus muscles
from sync+/+ and sync-/-
mice. EDL muscles from
sync-/- mice generated 27.9%
less force (25.86 N/cm2) than
from sync+/+ mice (35.89 N/
cm2). *p \ 0.05
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Interestingly, an investigation of contractile function in
isolated soleus and EDL demonstrated a reduction of
nearly 30% in the maximum force generated by sync-/-
EDL compared with sync+/+ EDL (although no difference
in the soleus analysis) (Fig. 5). EDL comprises mostly fast
(type II) myofibers, in contrast to soleus muscle which is
populated mainly by slow (type I) myofibers. The reduction
in maximum force generation seen in EDL may indicate




images (n = 3 for each
genotype at each time point) of
hemotoxylin and eosin staining
of 9–12-lm cryosections taken
from animals at 1, 3, 5, 7, and









of p21CIP1, p27KIP1, p57KIP2,
and myogenin RNA transcript
levels in tibialis anterior at 1, 3,
5, and 7 days following
cardiotoxin administration.
Images (which are
representative of n = 3 for each
genotype at each time point)
indicate no difference in
regeneration kinetics between
sync+/+ and sync-/- animals
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that syncoilin plays varying roles or has a variable
functional redundancy in different fiber types. The identi-
fication of a force reduction in sync-/- EDL is in
accordance with a similar analysis performed by Zhang
et al. (2008). Using an alternative syncoilin-null model
(generated by the introduction of a point mutation resulting
in the aberrant mRNA splicing of the second syncoilin
exon), this study reinforces the findings presented in our
own analysis, namely, that syncoilin appears to be largely
redundant for striated muscle development and regenera-
tion (Zhang et al. 2008).
Our analysis of serum CK levels following 3 weeks of
enforced treadmill exercise is the first report of a func-
tionally induced myopathy deriving from an absence of
syncoilin (Table 1). Elevated serum CK levels are widely
used as a marker of sarcolemmal damage. This finding is in
contrast to earlier studies performed on des-/- mice,
which failed to exhibit an increase in serum CK levels after
a bout of enforced treadmill exercise (Haulbold et al.
2003).
An analysis of serum CK levels in des-/- mice was
performed immediately following and 24 h after a brief
period of low-speed downhill running as described by
Vilquin et al. (1998) for use in the dystrophin mdx mouse
model (Haubold et al. 2003; Vilquin et al. 1998). The
results of this study did not show a difference in CK levels
between wild-type and des-/- animals either immediately
after or 1 day after exercise.
The mdx mouse is used as a model of dystrophin abla-
tion-induced muscular dystrophy and exhibits a severe
myopathic phenotype (Vilquin et al. 1998). The phenotype
of a des-/- mouse is far milder than that exhibited by the
mdx mouse, although des-/- mice still exhibit a reduction
in running ability when compared with wild-type animals
(Haubold et al. 2003). At a molecular level, a loss of
desmin does not appear to induce disruption of the essential
DAPC as is seen with a loss of dystrophin. Although it is
surprising that a loss of syncoilin induces an increase in
serum CK levels whereas a loss of desmin does not (given
the proposed role of syncoilin and the abundance of desmin
in mature myocytes), it is a possibility that the exercise
regimen applied to the des-/- mice was not sufficient in
either duration or intensity to induce sufficient damage to
cause mechanical stress.
The precise function of syncoilin remains undelineated.
However, we do possess several pieces of evidence that can
assist us in generating hypotheses about the role(s) of
syncoilin in muscle. Given that syncoilin is a member of
the IF protein family (at least at a sequence homology
level), we can reasonably expect that it plays a role in line
with that of other IF proteins, which, among others,
involves protecting cells from mechanical stress (Parry
et al. 2007). Syncoilin’s association with the DAPC and
other IF proteins (in particular, the finding that it binds to
desmin) adds weight to it having a structural role in mus-
cle. Our studies indicate that at least in an acute setting
there are sufficient mechanisms in existence in myocytes to
cope with a loss of syncoilin. One such potential com-
pensatory mechanism may exist in skeletal muscle in the
form of the type IV IF protein synemin, although it is worth
noting that there are significant size and structural differ-
ences between these two IF proteins.
Synemin is a large IF protein expressed in all types of
human muscle cells as two splice variants, a-synemin and
b-synemin (Sun et al. 2008). Synemin has been shown to
act as a binding partner for a range of cytoskeletal and
structural proteins and contains a binding site for a-actinin
(Bellin et al. 1999, 2001). Recent studies have indicated
that the two variants may play different roles in muscle,
with the ability to interact with vinculin and metavinculin
limited to a-synemin, which contains an additional C-ter-
minal 312-residue insert not found in b-synemin (Sun et al.
2008). Importantly for our investigation of syncoilin,
Fig. 7 Seven-day analysis of voluntary wheel running in sync+/+
and sync-/- mice. No significant difference was detected in the total
activity levels of the two groups
K. J. A. McCullagh et al.: Muscle function in the C57BL6/SV129 syncoilin knockout mouse 349
123
synemin has also been shown to act as a binding partner for
desmin and a-dystrobrevin, and the spatial organization of
synemin exhibits a number of parallels to that of syncoilin
(Bhosle et al. 2006). As such, it has the potential to act in a
compensatory role in a sync-/- system.
Our Western blot analysis for both H and M variants
(analogous to a and b variants in humans) of synemin
showed no difference in net protein levels between sync+/
+ and sync-/- mice, indicating that a lack of overt phe-
notype in the sync-/- mouse is not due to compensation
by synemin. It is possible, however, that the presence of
synemin in what appears to be a similar role in muscle
offsets or masks the deleterious effects of a loss of syn-
coilin, such that under normal laboratory cage or mild
exercise conditions, syncoilin exhibits a degree of func-
tional redundancy.
In summary, our investigations show that we have
generated a functional example of a syncoilin knockout
mouse model. Syncoilin-null mice do not display an overt
phenotype. An absence of syncoilin does not (in the pro-
teins investigated in this study) induce a compensatory
protein upregulation in skeletal muscle or the disruption of
protein localization in isolated fibers. No difference in
muscle regeneration following cardiotoxin-induced necro-
sis was observed, and an absence of syncoilin did not affect
voluntary or enforced exercise capacity.
The mechanical analysis of isolated muscle revealed a
significant alteration in contractile properties, indicating
that syncoilin may play a role in the lateral transmission of
force across contractile tissues. Most interestingly, we have
shown that under extended exercise conditions, an absence
of syncoilin predisposes muscle to increased damage.
Given the findings in this and other studies, it is possible
that the role of syncoilin is analogous to that of ‘‘a single
spoke in a wheel,’’ in that its structural role is not appre-
ciated (nor its absence noted) until significant levels of
mechanical stress are applied to the syncoilin-deficient
system.
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Fig. 8 Histologic analysis of
tibialis anterior (TA), soleus
(SOL), and extensor digitorum
longus (EDL) showing no overt
difference between sync+/+
and sync-/- mice (as assessed
by hemotoxylin and eosin
staining and Evans Blue
staining). Images are
representative of sections taken
from three animals per genotype
Table 1 Serum CK levels from running mouse cohort
Mouse ID Genotype CK U/I Mouse ID Genotype CK U/I
0 +/+ 188 0 -/- 741
1 +/+ 447 1 -/- 1161
3 +/+ 704 3 -/- 145
4 +/+ 410 4 -/- 1771
10 +/+ 184 10 -/- 1545
30 +/+ 243 30 -/- 616
+/+ Average 362.6 -/- Average 996.5
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